EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia

Tuntas Rayinda, Nick Dand, Sheila M McSweeney, Evangelos Christou, Chuin Ying Ung, Catherine M Stefanato, David A Fenton, Matthew Harries, Ioulios Palamaras, Alice Tidman, Susan Holmes, Anastasia Koutalopoulou und 22 weitere

JAMA Dermatology · 2025

DOI: 10.1001/jamadermatol.2024.6434 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift JAMA Dermatology, 2025. Verfasst von Tuntas Rayinda und 33 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology, King's College London, London, United Kingdom. Hauptthemen laut MEDLINE: Alopecia, Aminopeptidases, Epistasis, Genetic, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Frontal fibrosing alopecia (FFA) is an inflammatory and scarring form of hair loss of increasing prevalence that most commonly affects women. An improved understanding of the genetic basis of FFA will support the identification of pathogenic mechanisms and therapeutic targets.

Objective

To identify novel genomic loci at which common genetic variation affects FFA susceptibility and assess nonadditive effects on genetic risk between susceptibility loci. Design, Setting, and Participants Four genome-wide association studies were combined using an SE-weighted meta-analysis. Within the major histocompatibility complex (MHC) locus, stepwise conditional analysis was undertaken to determine independently associated classical MHC class I alleles. Statistical tests for epistatic interaction were performed between risk alleles at the MHC and endoplasmic reticulum aminopeptidase 1 ( ERAP1 ) loci. Main Outcomes and Measures Genome-wide significant locus associated with FFA and nonadditive effects on genetic risk between susceptibility loci.

Results

Of 6668 included patients, there were 1585 European female individuals with FFA and 5083 controls. Genome-wide significant associations were identified at 4 genomic loci, including a novel susceptibility locus at 5q15, and the association signal could be fine-mapped to a single nucleotide substitution (rs10045403) in the 5′ untranslated region of ERAP1 (rs10045403; odds ratio, 1.30; 95% CI, 1.19-1.43; P = 3.6 × 10 −8 ). Within the MHC, FFA risk was statistically independently associated with HLA-A*11:01, HLA-A*33:01, HLA-B*07:02, and HLA-B*35:01. FFA risk was affected by genetic variation at the ERAP1 locus only in individuals who carried at least 1 of the MHC class I risk alleles. Conclusions and Relevance In this genome-wide meta-analysis, a supra-additive effect of genetic variation was found that affected peptide trimming and antigen presentation on FFA susceptibility. Patients with FFA may benefit from emerging therapeutic approaches that modulate ERAP-mediated processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaAminopeptidasesEpistasis, GeneticHistocompatibility Antigens Class IMinor Histocompatibility AntigensFemaleHumansAllelesFibrosisGenetic Predisposition to DiseaseGenome-Wide Association StudyPolymorphism, Single Nucleotide

Substanzen

AminopeptidasesERAP1 protein, humanHistocompatibility Antigens Class IMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • St John's Institute of Dermatology, King's College London, London, United Kingdom.
  • Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
  • Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.
  • Centre for Dermatology Research, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
  • Department of Dermatology, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom.
  • Department of Dermatology, Barnet and Chase Farm Hospitals, Royal Free NHS Foundation Trust, London, United Kingdom.

Zitieren

APA

Rayinda, T., Dand, N., McSweeney, S. M., Christou, E., Ung, C. Y., Stefanato, C. M., Fenton, D. A., Harries, M., Palamaras, I., Tidman, A., Holmes, S., Koutalopoulou, A., Ardern-Jones, M., Kaur, M., Papanikou, S., Chasapi, V., Vañó-Galvan, S., Saceda-Corralo, D., Melián-Olivera, A., …, & Tziotzios, C. (2025). Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.6434

Vancouver

Rayinda T, Dand N, McSweeney SM, Christou E, Ung CY, Stefanato CM, et al. Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia. JAMA Dermatology. 2025. doi:10.1001/jamadermatol.2024.6434

BibTeX
@article{Rayinda2025,
  author = {Rayinda, Tuntas and Dand, Nick and McSweeney, Sheila M and Christou, Evangelos and Ung, Chuin Ying and Stefanato, Catherine M and Fenton, David A and Harries, Matthew and Palamaras, Ioulios and Tidman, Alice and Holmes, Susan and Koutalopoulou, Anastasia and Ardern-Jones, Michael and Kaur, Manjit and Papanikou, Sofia and Chasapi, Vasiliki and Vañó-Galvan, Sergio and Saceda-Corralo, David and Melián-Olivera, Ana and Azcarraga-Llobet, Carlos and Lobato-Berezo, Alejandro and Bustamante, Mariona and Sunyer, Jordi and Starace, Michela Valeria Rita and Piraccini, Bianca Maria and Wiss, Isabel Pupo and Senna, Maryanne Makredes and Singh, Rashmi and Hillmann, Kathrin and Kanti-Schmidt, Varvara and Blume-Peytavi, Ulrike and McGrath, John A and Simpson, Michael A and Tziotzios, Christos},
  title = {Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia},
  journal = {JAMA Dermatology},
  year = {2025},
  doi = {10.1001/jamadermatol.2024.6434}
}
Kostenlos starten →